Category: Healthcare and Pharmaceutical

DNA Strand-Themed Deal Toy

Lucite deal toy commemorating several U.S. private placements by Australia-based Sonic Healtcare.

(9AJH188)
2 Images
Lucite deal tombstone marking private placements by Sonic Healthcare. The diagnostic laboratory medicine firm is headquartered in Sydney, Australia.

Biotech Private Placement Corporate Tombstone

Crystal deal toy marking a private placement by Colorado-based pharmaceutical firm Aytu Bioscience.

(9AMF327)
2 Images
Side View of crystal deal tombstone commemorating a private placement by Aytu Bioscience. The commercial-stage pharmaceutical company is based in Englewood, Colorado.

Direct Offering Financial Tombstone

Financial tombstone marking a registered direct offering of common stock by CHF Solutions. The medical device company is headquartered in Minneapolis, Minnesota.

(9AMF329)
1 Image

Pill Bottle Lucite Tombstone

Lucite tombstone commemorating a joint venture between pharmaceutical firms Pfizer and GlaxoSmithKline. The joint venture centers on the over-the-counter consumer healthcare business.

(9AKL489)
2 Images
Custom deal toy celebrating a consumer healthcare joint venture involving the pharmaceutical firms Pfizer and GlaxoSmithKline.

Pill-Themed Crystal Deal Toy

Pill-themed crystal deal toy commemorating a license agreement between Asahi Kasei Pharma Corporation, headquartered in Tokyo, and New York-based Woolsey Pharmaceuticals.

(9AMF325)
1 Image

Senior Living Facilities Acquisition Tombstone

Lucite tombstone marking the acquisition of a senior living portfolio by Complete Care Management. Based in Howell, New Jersey, the firm provides short-term rehabilitation, long-term care, and specialty health services.

(9AMF262)
1 Image

Senior Living Facilities Deal Toy

Lucite deal toy commemorating the acquisition of a portfolio of senior living and skilled nursing facilities in Ocean County, New Jersey.

(k9AMF262)
1 Image

Custom Crystal for Distribution Agreement (Side View)

Custom crystal celebrating a commercial rights agreement between pharmaceutical firm Zogenix and Nippon Shinyaku. Zogenix focuses on rare disease therapies.

(9ALj481)
1 Image